These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
224 related items for PubMed ID: 14640552
21. Synthesis and antitumor characterization of pyrazolic analogues of the marine pyrroloquinoline alkaloids: wakayin and tsitsikammamines. Legentil L, Benel L, Bertrand V, Lesur B, Delfourne E. J Med Chem; 2006 May 18; 49(10):2979-88. PubMed ID: 16686539 [Abstract] [Full Text] [Related]
22. Synthesis and structure-activity relationships of new benzodioxinic lactones as potential anticancer drugs. Romero M, Renard P, Caignard DH, Atassi G, Solans X, Constans P, Bailly C, Pujol MD. J Med Chem; 2007 Jan 25; 50(2):294-307. PubMed ID: 17228871 [Abstract] [Full Text] [Related]
23. Synthesis and cytotoxic evaluation of combretafurazans. Tron GC, Pagliai F, Del Grosso E, Genazzani AA, Sorba G. J Med Chem; 2005 May 05; 48(9):3260-8. PubMed ID: 15857132 [Abstract] [Full Text] [Related]
24. Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones. Ferlin MG, Chiarelotto G, Gasparotto V, Dalla Via L, Pezzi V, Barzon L, Palù G, Castagliuolo I. J Med Chem; 2005 May 05; 48(9):3417-27. PubMed ID: 15857148 [Abstract] [Full Text] [Related]
25. Synthesis and structure-activity relationships of constrained heterocyclic analogues of combretastatin A4. Arthuis M, Pontikis R, Chabot GG, Seguin J, Quentin L, Bourg S, Morin-Allory L, Florent JC. ChemMedChem; 2011 Sep 05; 6(9):1693-705. PubMed ID: 21732536 [Abstract] [Full Text] [Related]
26. Synthesis of a new 4-aza-2,3-didehydropodophyllotoxin analogues as potent cytotoxic and antimitotic agents. Kamal A, Suresh P, Mallareddy A, Kumar BA, Reddy PV, Raju P, Tamboli JR, Shaik TB, Jain N, Kalivendi SV. Bioorg Med Chem; 2011 Apr 01; 19(7):2349-58. PubMed ID: 21402478 [Abstract] [Full Text] [Related]
27. Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity. Simoni D, Romagnoli R, Baruchello R, Rondanin R, Grisolia G, Eleopra M, Rizzi M, Tolomeo M, Giannini G, Alloatti D, Castorina M, Marcellini M, Pisano C. J Med Chem; 2008 Oct 09; 51(19):6211-5. PubMed ID: 18783207 [Abstract] [Full Text] [Related]
28. Synthesis and biological evaluation of distamycin analogues - new potential anticancer agents. Drozdowska D, Rusak M, Miltyk W, Midura-Nowaczek K. Arch Pharm (Weinheim); 2009 Feb 09; 342(2):87-93. PubMed ID: 19173336 [Abstract] [Full Text] [Related]
29. Novel combretastatin analogues effective against murine solid tumors: design and structure-activity relationships. Ohsumi K, Nakagawa R, Fukuda Y, Hatanaka T, Morinaga Y, Nihei Y, Ohishi K, Suga Y, Akiyama Y, Tsuji T. J Med Chem; 1998 Jul 30; 41(16):3022-32. PubMed ID: 9685242 [Abstract] [Full Text] [Related]
30. Antineoplastic agents. 487. Synthesis and biological evaluation of the antineoplastic agent 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene and derived amino acid amides. Pettit GR, Anderson CR, Herald DL, Jung MK, Lee DJ, Hamel E, Pettit RK. J Med Chem; 2003 Feb 13; 46(4):525-31. PubMed ID: 12570374 [Abstract] [Full Text] [Related]
31. Synthesis and antitumor activity of benzils related to combretastatin A-4. Mousset C, Giraud A, Provot O, Hamze A, Bignon J, Liu JM, Thoret S, Dubois J, Brion JD, Alami M. Bioorg Med Chem Lett; 2008 Jun 01; 18(11):3266-71. PubMed ID: 18477509 [Abstract] [Full Text] [Related]
32. 2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study. Basnet A, Thapa P, Karki R, Choi H, Choi JH, Yun M, Jeong BS, Jahng Y, Na Y, Cho WJ, Kwon Y, Lee CS, Lee ES. Bioorg Med Chem Lett; 2010 Jan 01; 20(1):42-7. PubMed ID: 19954977 [Abstract] [Full Text] [Related]
33. New antitubulin derivatives in the combretastatin A4 series: synthesis and biological evaluation. Borrel C, Thoret S, Cachet X, Guénard D, Tillequin F, Koch M, Michel S. Bioorg Med Chem; 2005 Jun 01; 13(11):3853-64. PubMed ID: 15863010 [Abstract] [Full Text] [Related]
34. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. Kemnitzer W, Drewe J, Jiang S, Zhang H, Wang Y, Zhao J, Jia S, Herich J, Labreque D, Storer R, Meerovitch K, Bouffard D, Rej R, Denis R, Blais C, Lamothe S, Attardo G, Gourdeau H, Tseng B, Kasibhatla S, Cai SX. J Med Chem; 2004 Dec 02; 47(25):6299-310. PubMed ID: 15566300 [Abstract] [Full Text] [Related]
35. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents. Romagnoli R, Baraldi PG, Pavani MG, Tabrizi MA, Preti D, Fruttarolo F, Piccagli L, Jung MK, Hamel E, Borgatti M, Gambari R. J Med Chem; 2006 Jun 29; 49(13):3906-15. PubMed ID: 16789746 [Abstract] [Full Text] [Related]
36. Antitumor agents. 174. 2',3',4',5,6,7-Substituted 2-phenyl-1,8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. Chen K, Kuo SC, Hsieh MC, Mauger A, Lin CM, Hamel E, Lee KH. J Med Chem; 1997 Jul 04; 40(14):2266-75. PubMed ID: 9216846 [Abstract] [Full Text] [Related]
37. 2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship. Basnet A, Thapa P, Karki R, Na Y, Jahng Y, Jeong BS, Jeong TC, Lee CS, Lee ES. Bioorg Med Chem; 2007 Jul 01; 15(13):4351-9. PubMed ID: 17493824 [Abstract] [Full Text] [Related]
38. Amidine analogues of melphalan: synthesis, cytotoxic activity, and DNA binding properties. Bielawska A, Bielawski K, Anchim T. Arch Pharm (Weinheim); 2007 May 01; 340(5):251-7. PubMed ID: 17458920 [Abstract] [Full Text] [Related]
39. Synthesis of anticancer beta-lactams: mechanism of action. Banik BK, Becker FF, Banik I. Bioorg Med Chem; 2004 May 15; 12(10):2523-8. PubMed ID: 15110834 [Abstract] [Full Text] [Related]
40. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand. Marzano C, Pellei M, Colavito D, Alidori S, Lobbia GG, Gandin V, Tisato F, Santini C. J Med Chem; 2006 Dec 14; 49(25):7317-24. PubMed ID: 17149861 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]